"Our meta-analysis highlights a link between SARS-CoV-2 vaccination and new onset or worsening of inflammatory and autoimmune skin diseases," the study authors write.
The ruling mandates that the FDA, which initially proposed a release timeline of approximately 23.5 years, must now disclose all relevant documents by mid-2025.
